we serve today proudly the largest employers health plans and government agencies and we'll continueat forward. the space is a regulated space, so we'll continue to lean into regulation and ensure that we are delivering real value in the market. >> david cordani, we'll leave it there. thank you so much for joining us. >> thanks for having me today. >> dom, back to you. >> all right. thank you very much for the interview. >>> take a look by the way at shares of novo nortis, surging to a record high. a phase one trial result for its experimental obesity pill is positive. participants averaged 13% weight loss after taking the drug for 12 weeks, suggesting the oral treatment would be more effective than wegovy. and the ceo will be on "money movers" tomorrow at 11:00 a.m. eastern time. >>> and if you missed the premiere last week of cnbc's latest documentary, "big shot," which is the ozempic revolution, it's available now on demands and streaming on peacock later this month. >>> right now, we turn to l rivian. and we have more on that story. let's talk about the results of why rivian is m